IL-17 and its Receptor Complex as Therapeutic Targets in Arthritis

E-ISSN： 1875-6115|8|3|247-251

ISSN： 1871-5222

Source： Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Immunology, Endocrine and Metabolic Agents), Vol.8, Iss.3, 2008-09, pp. : 247-251

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Interleukin-17 and Its Receptor

By Spriggs Melanie K.

Journal of Clinical Immunology, Vol. 17, Iss. 5, 1997-09 ,pp. : 366-369

Springer Publishing Company

Access to resources Recommend Favorite

IL-23/IL-17 Biology and Therapeutic Considerations

By Dong Chen

Journal of Immunotoxicology, Vol. 5, Iss. 1, 2008-12 ,pp. : 43-46

Informa Healthcare

Access to resources Recommend Favorite

EGF and PDGF Receptor Tyrosine Kinases as Therapeutic Targets for Chronic Lung Diseases

Current Molecular Medicine, Vol. 6, Iss. 4, 2006-06 ,pp. : 409-421

Bentham Science Publishers

Access to resources Recommend Favorite

IL-6 inhibits the proliferation of fibroblastic synovial cells from rheumatoid arthritis patients in the presence of soluble IL-6 receptor

By Tomita T.

International Immunology, Vol. 12, Iss. 2, 2000-02 ,pp. : 187-193

Oxford University Press

Access to resources Recommend Favorite

IL-1 Receptor Antagonist (IL-1RA) Gene Polymorphism in Sjogren's Syndrome and Rheumatoid Arthritis

By Perrier S. Coussediere C. Dubost J.J. Albuisson E. Sauvezie B.

Clinical Immunology, Vol. 87, Iss. 3, 1998-06 ,pp. : 309-313

Academic Press

Access to resources Recommend Favorite